p.81 抽出テキスト

CLINICAL STATEMENTS AND GUIDELINES

Circulation. 2023;148:e9–e119. DOI: 10.1161/CIR.0000000000001168 August 29, 2023

Virani et al 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Chronic Coronary Disease Guideline

3.	 Ostbring MJ, Eriksson T, Petersson G, et al. Effects of a pharmaceutical care intervention on clinical outcomes and patient adherence in coronary heart disease: the MIMeRiC randomized controlled trial. BMC Cardiovasc Disord. 2021;21:367. 4.	 Agency for Healthcare Research and Quality. Medication Adherence Interventions: Closing the Quality Gap: Revisiting the State of the Science: Executive Summary. AHRQ; 2012. AHRQ Pub. No. 12-E010-1. Published online September 2012. Accessed November 27, 2021. https://effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_executive.pdf. 5.	 Anderson L, Brown JP, Clark AM, et al. Patient education in the management of coronary heart disease. Cochrane Database Syst Rev. 2017;6:CD008895. 6.	 Clark AM, Hartling L, Vandermeer B, et al. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005;143:659–672. 7.	 Wallert J, Olsson EM, Pingel R, et al. Attending Heart School and long-term outcome after myocardial infarction: a decennial SWEDEHEART registry study. Eur J Prev Cardiol. 2020;27:145–154. 8.	 Palacios J, Lee GA, Duaso M, et al. Internet-delivered self-management support for improving coronary heart disease and self-management-related outcomes: a systematic review. J Cardiovasc Nurs. 2017;32:e9–e23. 9.	 Institute of Medicine. Health Literacy: A Prescription to End Confusion. The National Academies Press; 2004 10.	 Brega AG, Barnard J, Mabachi NM, et al. AHRQ Health Literacy Universal Precautions Toolkit. 2nd ed. AHRQ; 2015. AHRQ Pub. No. 15-0023-EF. Accessed December 15, 2021. https://www.ahrq.gov/sites/default/files/ publications/files/healthlittoolkit2_3.pdf. 11.	 Smith DH, Kramer JM, Perrin N, et al. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med. 2008;168:477–483; discussion 483; quiz 447. 12.	 Wilhelmsen NC, Eriksson T. Medication adherence interventions and out-

comes: an overview of systematic reviews. Eur J Hosp Pharm. 2019;26:187– 192. 4.1.3. Shared Decision-Making 1.	 Provance JB, Spertus JA, Decker C, et al. Assessing patient preferences for shared decision-making in peripheral artery disease. Circ Cardiovasc Qual Outcomes. 2019;12:e005730. 2.	 Jansen J, McKinn S, Bonner C, et al. Shared decision-making about cardiovascular disease medication in older people: a qualitative study of patient experiences in general practice. BMJ Open. 2019;9:e026342. 3.	 Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making?. Arch Intern Med. 1996;156:1414–1420. 4.	 Coylewright M, Dick S, Zmolek B, et al. PCI choice decision aid for stable coronary artery disease: a randomized trial. Circ Cardiovasc Qual Outcomes. 2016;9:767–776. 5.	 Krumholz HM, Barreto-Filho JA, Jones PG, et al. Decision-making preferences among patients with an acute myocardial infarction. JAMA Intern Med. 2013;173:1252–1257. 6.	 Stacey D, Legare F, Lewis K, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2017;4:CD001431. 7.	 Scalia P, Saunders CH, Dannenberg M, et al. Processes for evidence summarization for patient decision aids: a Delphi consensus study. Health Expect. 2021;24:1178–1186. 8.	 Witteman HO, Maki KG, Vaisson G, et al. Systematic development of patient decision aids: an update from the IPDAS collaboration. Med Decis Making. 2021;41:736–754. 9.	 Bonner C, Trevena LJ, Gaissmaier W, et al. Current best practice for pre-

senting probabilities in patient decision aids: fundamental principles. Med Decis Making. 2021;41:821–833. 4.1.4. Social Determinants of Health 1.	 Jilani MH, Javed Z, Yahya T, et al. Social determinants of health and cardiovascular disease: current state and future directions towards healthcare equity. Curr Atheroscler Rep. 2021;23:55. 2.	 Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018;137:2166– 2178. 3.	 Lindley KJ, Aggarwal NR, Briller JE, et al. Socioeconomic determinants of health and cardiovascular outcomes in women: JACC review topic of the week. J Am Coll Cardiol. 2021;78:1919–1929. 4.	 Moen M, Storr C, German D, et al. A review of tools to screen for social

determinants of health in the United States: a practice brief. Popul Health Manag. 2020;23:422–429. 5 Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and

low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289:3106–3116. 6.	 Kawachi I, Colditz GA, Ascherio A, et al. A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health. 1996;50:245–251. 7.	 Fiscella K, Tancredi D, Franks P. Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment. Am Heart J. 2009;157:988–994. 8.	 Brindle PM, McConnachie A, Upton MN, et al. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract. 2005;55:838–845. 9.	 Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–e646. 10.	 Havranek EP, Mujahid MS, Barr DA, et al. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132:873–898. 11.	 World Health Organization. Closing the gap in a generation: health equity through action on the social determinants of health 2008. Accessed December 20, 2021. https://www.who.int/social_determinants/thecommission/finalreport/en/. 12.	 Mital R, Bayne J, Rodriguez F, et al. Race and ethnicity considerations in patients with coronary artery disease and stroke: JACC focus seminar 3/9. J Am Coll Cardiol. 2021;78:2483–2492. 13.	 Hammond G, Joynt-Maddox KE. A theoretical framework for clinical implementation of social determinants of health. JAMA Cardiol. 2019;4:1189– 1190. 14.	 Roger VL. Medicine and society: social determinants of health and cardiovascular disease. Eur Heart J. 2020;41:1179–1181. 15.	 Lloyd-Jones DM, Elkind M, Albert MA. American Heart Association's 2024 impact goal: every person deserves the opportunity for a full, healthy life. Circulation. 2021;144:e277–e279. 16.	 Butkus R, Rapp K, Cooney TG, et al. Envisioning a better U.S. health care system for all: reducing barriers to care and addressing social determinants of health. Ann Intern Med. 2020;172:S50–S59. 17.	 Arons A, DeSilvey S, Fichtenberg C, et al. Documenting social determinants of health-related clinical activities using standardized medical vocabularies. JAMA Open. 2019;2:81–88. 18.	 Angell SY, McConnell MV, Anderson CAM, et al. The American Heart Association 2030 impact goal: a presidential advisory from the American Heart Association. Circulation. 2020;141:e120–e138. 19.	 Itchhaporia D. Paving the way for health equity in cardiology: why does it matter?. J Am Coll Cardiol. 2021;77:2613–2616. 20.	 Caceres BA, Streed CG Jr, Corliss HL, et al. Assessing and addressing cardiovascular health in LGBTQ adults: a scientific statement from the American Heart Association. Circulation. 2020;142:e321–e332. 21.	 Streed CG Jr, Beach LB, Caceres BA, et al. Assessing and addressing cardiovascular health in people who are transgender and gender diverse: a scientific statement from the American Heart Association. Circulation. 2021;144:e136–e148. 22.	 Billioux A, Verlander K, Anthony S, et al. Standardized screening for healthrelated social needs in clinical settings: the Accountable Health Communities Screening Tool. NAM Perspectives Discussion Paper, National Academy of Medicine. Washington, DC; 2017. 23.	 Tong ST, Liaw WR, Kashiri PL, et al. Clinician experiences with screening for social needs in primary care. J Am Board Fam Med. 2018;31:351–363. 24.	 Palacio A, Mansi R, Seo D, et al. Social determinants of health score: does it help identify those at higher cardiovascular risk?. Am J Manag Care. 2020;26:e312–e318. 25.	 Magnani JW, Mujahid MS, Aronow HD, et al. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association. Circulation. 2018;138:e48–e74. 26.	 Brush JE Jr, Handberg EM, Biga C, et al. 2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers. J Am Coll Cardiol. 2015;65:2118–2136. 27.	 Gaziano T, Abrahams-Gessel S, Surka S, et al. Cardiovascular disease screening by community health workers can be cost-effective in low-resource countries. Health Aff (Millwood). 2015;34:1538–1545. 28.	 Lapidos A, Lapedis J, Heisler M. Realizing the value of community health

workers: new opportunities for sustainable financing. N Engl J Med. 2019;380:1990–1992.

Downloaded from http://ahajournals.org by on October 7, 2026